HB 4409 – Michigan

Status: In Process
Year Introduced: 2023
Link: http://legislature.mi.gov/doc.aspx?2023-HB-4409

House Bill 4409 would create a new act, the Drug Manufacturer Data Reporting Act, which would require drug manufacturers to disclose certain information on costs and pricing to the Department of Insurance and Financial Services (DIFS) on an annual basis. The reports and information would be exempt from disclosure under the Freedom of Information Act (FOIA). DIFS could promulgate rules to implement the act

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found